Currently, no vaccines or therapeutics are licensed to counter Ebola or Marburg viruses, highly pathogenic filoviruses that are causative agents of viral hemorrhagic fever. Here we show that administration of positively charged phosphorodiamidate morpholino oligomers (PMOplus), delivered by various dosing strategies initiated 30-60 min after infection, protects>60% of rhesus monkeys against lethal Zaire Ebola virus (ZEBOV) and 100% of cynomolgus monkeys against Lake Victoria Marburg virus (MARV) infection. PMOplus may be useful for treating these and other highly pathogenic viruses in humans.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/nm.2202 | DOI Listing |
Publication Analysis
Top Keywords
highly pathogenic
8
advanced antisense
4
antisense therapies
4
therapies postexposure
4
postexposure protection
4
protection lethal
4
lethal filovirus
4
filovirus infections
4
infections currently
4
currently vaccines
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!